Skip to main content

Noninvasive Characterization of Tumor Angiogenesis and Oxygenation in Bevacizumab-treated Recurrent Glioblastoma by Using Dynamic Susceptibility MRI: Secondary Analysis of the European Organization for Research and Treatment of Cancer 26101 Trial.

Kickingerede P, Brugnara G, Hansen MB, et al. Radiology. 2020;200978

Our unique biomarkers were used in a study to evaluate the effectiveness of the bevacizumab treatment.

Get full access to the article doi:10.1148/radiol.2020200978